Dr. Eric R. Wiedower, DO

Dr. Wiedower practices at West Cancer Center - East Campus in Germantown, Tennessee.

Dr. Wiedower's NPI, 1154633857, was assigned on July 10, 2010. Dr. Wiedower holds Tennessee license 3015.

Dr. Wiedower's primary practice is West Cancer Center - East Campus, at 7714 Poplar Ave, Germantown, TN 38138 in Shelby County. The practice phone is (901) 683-0055.

Dr. Wiedower's primary practice is West Cancer Center - East Campus in Germantown, Tennessee. Dr. Wiedower is also affiliated with Baptist Memorial Hospital-DeSoto. The medical group on file is The West Clinic. Dmand AI also links Dr. Wiedower to 4 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wiedower practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wiedower's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Wiedower's licenses on file in 2 states: Tennessee and Mississippi.

CMS data shows 168,646 Medicare services from Dr. Wiedower across 72 procedure codes in 2024, for 983 Medicare patients. Medicare paid $3,390,701 for them.

CMS counts 983 Medicare patients who saw Dr. Wiedower in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wiedower's median patient age at 67, with 63% women.

In 2024, Dr. Wiedower wrote 1,967 Medicare Part D claims for 309 patients. 73% of them were for generic drugs. CMS names the drug for 1,582 of them, across 46 drugs with 11 or more claims each, at $4,471,816 in total drug cost. In 2023, CMS named 1,650 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Wiedower for performance year 2024. Dr. Wiedower accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wiedower as offering telehealth.

Dmand AI links 8 papers to Dr. Wiedower, published from 2015 to 2018. 2016 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Wiedower has published most often in Anticancer Res. Dr. Wiedower's most frequent co-authors are George Yaghmour, Omer Hassan Jamy and Smith Giri.

CMS Open Payments shows 914 general payments to Dr. Wiedower from 77 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,467.